Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years

被引:0
|
作者
William Fusi-Rubiano
Chandoshi Mukherjee
Mark Lane
Marie D. Tsaloumas
Nicholas Glover
Andrej Kidess
Alastair K. Denniston
Helen E. Palmer
Avinash Manna
Rupal Morjaria
机构
[1] Queen Elizabeth Hospital Birmingham,Ophthalmology Department
[2] University Hospitals Birmingham NHSFT,undefined
[3] Sandwell & West Birmingham NHS Trust,undefined
[4] Academic Unit of Ophthalmology,undefined
[5] Institute of Inflammation & Ageing,undefined
[6] University of Birmingham,undefined
来源
关键词
Diabetic Macular Oedema; Iluvien; Diabetic Retinopathy; Fluocinolone Acetonide implant;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years
    Fusi-Rubiano, William
    Mukherjee, Chandoshi
    Lane, Mark
    Tsaloumas, Marie D.
    Glover, Nicholas
    Kidess, Andrej
    Denniston, Alastair K.
    Palmer, Helen E.
    Manna, Avinash
    Morjaria, Rupal
    BMC OPHTHALMOLOGY, 2018, 18
  • [2] Iluvien (Fluocinolone Acetonide 0.19mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    Fusi-Rubiano, William
    Blow, Rebecca R.
    Lane, Mark
    Morjaria, Rupal
    Denniston, Alastair K.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 293 - 305
  • [3] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Yahiya Y. Syed
    Drugs, 2017, 77 : 575 - 583
  • [4] Fluocinolone Acetonide Intravitreal Implant (Iluvien®)In Diabetic Macular Oedema
    Mark Sanford
    Drugs, 2013, 73 : 187 - 193
  • [5] Fluocinolone Acetonide Intravitreal Implant (Iluvien®) In Diabetic Macular Oedema
    Sanford, Mark
    DRUGS, 2013, 73 (02) : 187 - 193
  • [6] Fluocinolone Acetonide Intravitreal Implant 0.19 mg (ILUVIEN®): A Review in Diabetic Macular Edema
    Syed, Yahiya Y.
    DRUGS, 2017, 77 (05) : 575 - 583
  • [7] Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema
    Morozova, Christine
    Humayun, Lucas L.
    Kasper, Jonathan
    Morozov, Andy
    Tabandeh, Homayoun
    Boyer, David S.
    Dayani, Pouya N.
    Rahhal, Firas M.
    JOURNAL OF VITREORETINAL DISEASES, 2024, 8 (04) : 394 - 400
  • [8] Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2018, 7 : 293 - 305
  • [9] Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2020, 9 : 205 - 205
  • [10] Intravitreal fluocinolone acetonide implant (ILUVIEN®) for diabetic macular oedema: a literature review
    Massa, Horace
    Nagar, Anindyt M.
    Vergados, Athanasios
    Dadoukis, Panagiotis
    Patra, Sudeshna
    Panos, Georgios D.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (01) : 31 - 43